ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Apr 2026
Jan 2026
Latest Journal Issues
Nuclear Science and Engineering
May 2026
Nuclear Technology
February 2026
Fusion Science and Technology
Latest News
DTRA’s advancements in nuclear and radiological detection
A new, more complex nuclear age has begun. Echoing the tensions of the Cold War amid rapidly evolving nuclear and radiological threats, preparedness in the modern age is a contest of scientific innovation. The Research and Development Directorate (RD) at the Defense Threat Reduction Agency (DTRA) is charged with winning this contest.
Technical Session|Panel|Sponsored by RPD
Tuesday, June 14, 2022|10:15AM–12:00PM PDT|Carmel
Session Chair:
Yasir Arafat
Alternate Chair:
Abdalla Abou-Jaoude
Session Organizer:
The purpose of the MARVEL project is to develop, in less than 2 years, a nuclear microreactor applications test bed at INL to perform research and development on various operational features of microreactors to ultimately improve integration of microreactors to end-user applications. Through collaboration between the DOE Microreactor Program and the National Reactor Innovation Center (NRIC), the development of this test bed provides an opportunity to establish and exercise key NRIC capabilities that support future reactor demonstrations by: (1) providing an early-stage platform for potential end users of microreactor systems, (2) deploying the first small-scale R&D reactor in 40 years to support new capability development, (3) facilitating outreach activity with stakeholders interested in novel nuclear energy applications (e.g., hydrogen production, process heating, water purifications), and (4) investigating and addressing issues relating to fabrication, assembly, rapid installation, deployment, and operation of microreactors. The panel will provide an overview of the MARVEL from the perspective of key contributors and stakeholders.
INL
John Jackson
Jess Gehin
Associate Lab Director, Nuclear Science and Technology, Idaho National Laboratory
Shannon Bragg-Sitton
Jhansi Kandasamy
INL Net Zero Director
To join the conversation, you must be logged in and registered for the meeting.
Register NowLog In